[account_shop_links]
Biosimilar Primer: US Primary Care Physicians’ Attitudes, Beliefs, and Intentions
$750.00 – $1,500.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
As many US states are currently moving to create their own biosimilar legislation, the impact these products could and will have on the US healthcare industry remains in limbo. As your organization continues to develop and execute your biosimilar strategy, understanding various stakeholder needs, biases, and perceptions will be necessary.
What you will learn:
- The level of familiarity physicians have with biosimilars
- Intentions for prescribing based on biosimilar pricing
- Thoughts on pharmacy switching
- Beliefs on the required clinical development process for approval
Report Contents:
- Executive Summary
- Familiarity with Biosimilars
- Prescribing and Pricing
- Switching and DAW Preferences
- Clinical Development Preferences
